Short Oral Presentation Award 2022: Intra-Articular Injection of Mitochondria to Treat Osteoarthritis

Mercedes Fernandez-Moreno, Instituto de Investigación Biomédica de A Coruña (INIBIC), Spain, was discerned the best short oral presentation award for her innovative talk on the Approach for Using Intra-Articular Injection of Mitochondria to Treat Osteoarthritis.

Nowadays there is not cure or an efficient treatment for osteoarthritis (OA), despite of its the most common rheumatology illness and a major cause of pain and disability in older adults. The relation between mitochondria alteration and OA was described in several studies in which the authors explained how mitochondrial alteration can modulate the chondrocyte function and its survival during this pathogenesis

Mitochondria have proposed as a potential therapeutic target for OA. Dr. Fernandez-Moreno and her team hypothesized that transplantation of heterologous mitochondria from healthy donor would ameliorate the OA effects. The analysis of in vivo model showed that mitochondria injection was safety and no inflammatory response was observed in the joint. These preliminary data gave them the possibility to continue studying the mitochondrial transplantation as an efficient treatment for OA.

Dr. Fernandez-Moreno stated to the World Mitochondria Society: "Taken into account our preliminary data, we will continue in the develop of more robust data generating a complete in vivo model to confirm the role of healthy mitochondria over the OA cartilage."

In case you missed Dr. Fernandez-Moreno's winning presentation, you can access the conference material here.

Targeting Mitochondria 2022 Congress
October 26-28, 2022 - Berlin, Germany 
wms-site.com